Skip to content
value.today

STERRX, LLC

🇺🇸 Plattsburgh, New York, USAPharmaceuticalsFounded 2013
Total raised
$18 M
2 rounds on record
Latest round
$15 M
Sep 2017
First round on record
Mar 2016
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of STERRX, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2017$15 MNo. 2$10 to $50 million

STERRX, LLC: Raise no. 2, Sep 2017

Investors in this round

1 investor had bought by the notice of Sep 21, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
$15,000,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in New York

People named in the notice

  • Gary L Hanley · Executive Officer, Director · CEO and Manager
  • Terry L Wiley · Executive Officer, Director · Productions Officer, Manager
  • Vera L Delorme · Executive Officer · Secretary
  • Carl L Martin · Director · Manager
  • Jeff L LaBombard · Director · Manager
  • Kent L Smeltz · Director · Manager
  • Sandra L Hawkins · Director · Manager
  • Tana L Hanley · Director · Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gary L. Hanley, Ceo. Source: SEC Form D, newest notice filed Sep 21, 2017. Read the notice at the SEC.

equitySEC
Mar 2016$3 MNo. 1$2 to $10 million

STERRX, LLC: Raise no. 1, Mar 2016

Investors in this round

2 investors had bought by the notice of Mar 30, 2016: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
$1,500,000
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in New York

People named in the notice

  • Gary L. Hanley · Executive Officer, Director · CEO and Manager of Sterrx, LLC, President and Board Member of Asept Pak, Inc
  • James, III L. McKee · Executive Officer · CFO Sterrx, LLC; CFO Asept Pak, Inc.
  • Sandra L. Hawkins · Executive Officer, Director · Secretary and Manager, Sterrx, LLC. Secretary and Board Member, Asept Pak, Inc.
  • Terry L. Wiley · Executive Officer, Director · Manager, Sterrx, LLC. VP and Board Member of Asept Pak, Inc.
  • Tana L. Hanley · Director · Manager of Sterrx, LLC; VP and board member of Asept Pak, Inc

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Gary L. Hanley, President. Source: SEC Form D, newest notice filed Mar 30, 2016. Read the notice at the SEC.

equity, debtSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • STERRX, LLC chose not to state its revenue in its newest notice of a funding round (Sep 2017).

    SEC Form D · Sep 2017

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Sep 2017

That is all the official record says: STERRX, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of STERRX, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 2 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by STERRX, LLC
NameRoleNamed in
Gary L HanleyCEO and ManagerSep 2017
Terry L WileyProductions Officer, ManagerSep 2017
Vera L DelormeSecretarySep 2017
Gary L. HanleyCEO and Manager of Sterrx, LLC, President and Board Member of Asept Pak, IncMar 2016
James, III L. McKeeCFO Sterrx, LLC; CFO Asept Pak, Inc.Mar 2016
Sandra L. HawkinsSecretary and Manager, Sterrx, LLC. Secretary and Board Member, Asept Pak, Inc.Mar 2016
Terry L. WileyManager, Sterrx, LLC. VP and Board Member of Asept Pak, Inc.Mar 2016
Carl L MartinManagerSep 2017
Gary L HanleyCEO and ManagerSep 2017
Jeff L LaBombardManagerSep 2017
Kent L SmeltzManagerSep 2017
Sandra L HawkinsManagerSep 2017
Tana L HanleyManagerSep 2017
Terry L WileyProductions Officer, ManagerSep 2017
Gary L. HanleyCEO and Manager of Sterrx, LLC, President and Board Member of Asept Pak, IncMar 2016
Sandra L. HawkinsSecretary and Manager, Sterrx, LLC. Secretary and Board Member, Asept Pak, Inc.Mar 2016
Tana L. HanleyManager of Sterrx, LLC; VP and board member of Asept Pak, IncMar 2016
Terry L. WileyManager, Sterrx, LLC. VP and Board Member of Asept Pak, Inc.Mar 2016